Wolfgang Fleischhacker

3.2k total citations
28 papers, 1.5k citations indexed

About

Wolfgang Fleischhacker is a scholar working on Psychiatry and Mental health, Clinical Psychology and Biological Psychiatry. According to data from OpenAlex, Wolfgang Fleischhacker has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 6 papers in Clinical Psychology and 4 papers in Biological Psychiatry. Recurrent topics in Wolfgang Fleischhacker's work include Schizophrenia research and treatment (15 papers), Bipolar Disorder and Treatment (6 papers) and Tryptophan and brain disorders (4 papers). Wolfgang Fleischhacker is often cited by papers focused on Schizophrenia research and treatment (15 papers), Bipolar Disorder and Treatment (6 papers) and Tryptophan and brain disorders (4 papers). Wolfgang Fleischhacker collaborates with scholars based in Austria, United States and Germany. Wolfgang Fleischhacker's co-authors include Georg Kemmler, René S. Kahn, Elisabeth M. Weiss, Bernhard Holzner, Roland Moschèn, Barbara Sperner‐Unterweger, Silvana Galderisi, Martina Hummer, Michael Davidson and Alex Hofer and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Neurochemistry.

In The Last Decade

Wolfgang Fleischhacker

26 papers receiving 1.5k citations

Peers

Wolfgang Fleischhacker

PMH

PHILO

CMN

P. Tran United States

Katherine Beck United Kingdom

Kyung Sue Hong South Korea

Stephen J. Kaar United Kingdom

Allan Z. Safferman United States

Steven J. Romano United States

Eduard Parellada Spain

Suzanne Reeves United Kingdom

Olli Kampman Finland

Nicholas A Keks Australia

P. Tran United States

Wolfgang Fleischhacker

1.2k ×1.3

PMH

292 ×1.2

167 ×0.7

266 ×1.3

PHILO

212 ×1.2

CMN

Citations per year, relative to Wolfgang Fleischhacker Wolfgang Fleischhacker (= 1×) peers P. Tran

Countries citing papers authored by Wolfgang Fleischhacker

Since Specialization

Citations

This map shows the geographic impact of Wolfgang Fleischhacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Fleischhacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Fleischhacker more than expected).

Fields of papers citing papers by Wolfgang Fleischhacker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Fleischhacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Fleischhacker. The network helps show where Wolfgang Fleischhacker may publish in the future.

Co-authorship network of co-authors of Wolfgang Fleischhacker

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Fleischhacker. A scholar is included among the top collaborators of Wolfgang Fleischhacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Fleischhacker. Wolfgang Fleischhacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleischhacker, Wolfgang, Silvana Galderisi, I. Laszlovszky, et al.. (2019). The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors. European Psychiatry. 58. 1–9. 86 indexed citations

Dazzan, Paola, Francesco Carletti, Celso Arango, et al.. (2018). 31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS. Schizophrenia Bulletin. 44(suppl_1). S50–S51. 1 indexed citations

Bugarski‐Kirola, Dragana, Thomas Blaettler, Celso Arango, et al.. (2016). Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies. Biological Psychiatry. 82(1). 8–16. 109 indexed citations

Savitz, Adam, Haiyan Xu, Srihari Gopal, et al.. (2016). Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study. The International Journal of Neuropsychopharmacology. 19(7). pyw018–pyw018. 128 indexed citations

Hoertnagl, Christine M., Nursen Yalcin-Siedentopf, Susanne E. Baumgartner, et al.. (2014). Affective prosody perception in symptomatically remitted patients with schizophrenia and bipolar disorder. Schizophrenia Research. 158(1-3). 100–104. 14 indexed citations

Marques, Tiago Reis, Stephen Z. Levine, Avi Reichenberg, et al.. (2014). How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses. European Neuropsychopharmacology. 24(8). 1279–1288. 13 indexed citations

Edlinger, Monika, Klaus Seppi, Wolfgang Fleischhacker, & Alex Hofer. (2013). Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington’s disease. International Clinical Psychopharmacology. 1–1. 11 indexed citations

Park, Min-Hyeon, et al.. (2011). Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment. Expert Review of Neurotherapeutics. 11(11). 1541–1552. 13 indexed citations

Goodwin, Guy M., Wolfgang Fleischhacker, Celso Arango, et al.. (2011). Ventajas y desventajas del tratamiento de combinación con antipsicóticos. Reunión ECNP Consensus, marzo de 2008, Niza. Psiquiatría Biológica. 18(2). 55–67.

10.

Hofer, Alex, Falko Biedermann, Nursen Yalcin-Siedentopf, & Wolfgang Fleischhacker. (2010). [Neurocognition and social cognition in patients with schizophrenia or mood disorders].. PubMed. 24(3). 161–9. 10 indexed citations

11.

Goodwin, Guy M., Wolfgang Fleischhacker, Celso Arango, et al.. (2009). Advantages and disadvantages of combination treatment with antipsychotics. European Neuropsychopharmacology. 19(7). 520–532. 106 indexed citations

12.

Galderisi, Silvana, Michael Davidson, René S. Kahn, et al.. (2009). Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study. Schizophrenia Research. 115(2-3). 104–114. 95 indexed citations

13.

Kane, John M., et al.. (2009). Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics. The Journal of Clinical Psychiatry. 70(5). 627–643. 110 indexed citations

14.

Fleischhacker, Wolfgang & René S. Kahn. (2008). EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS IN FIRST-EPISODE SCHIZOPHRENIA AND SCHIZOPHRENIFORMDISORDER. Schizophrenia Research. 102(1-3). 48–48. 4 indexed citations

15.

Rettenbacher, Maria A., Alex Hofer, Ursula Eder, et al.. (2004). Compliance in Schizophrenia: Psychopathology, Side Effects, and Patients’ Attitudes Toward the Illness and Medication. The Journal of Clinical Psychiatry. 65(9). 1211–1218. 100 indexed citations

16.

Salimi, Kayvon, Christian Humpel, Nicolas Singewald, et al.. (2003). Differential effects of phencyclidine application on secretogranin II expression in organotypic slices of rat prefrontal cortex. Journal of Neurochemistry. 87(1). 13–21. 4 indexed citations

17.

Sperner‐Unterweger, Barbara, Bernhard Holzner, Andreas Laich, et al.. (2002). Immunologic Alterations in Schizophrenia: Neopterin, L-Kynurenine, Tryptophan and T-Cell Subsets in the Acute Stage of Illness. Pteridines. 13(1). 9–14. 3 indexed citations

18.

Weiss, Elisabeth M., Robert M. Bilder, & Wolfgang Fleischhacker. (2002). The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia. Psychopharmacology. 162(1). 11–17. 49 indexed citations

19.

Holzner, Bernhard, Georg Kemmler, Martin Kopp, et al.. (2001). Quality of Life in Breast Cancer Patients—Not Enough Attention for Long-Term Survivors?. Psychosomatics. 42(2). 117–123. 178 indexed citations

20.

Miller, Carl, Rudolf Kirchmair, Josef Troger, et al.. (1996). CSF of neuroleptic-naive first-episode schizophrenic patients: Levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). Biological Psychiatry. 39(11). 911–918. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact